Literature DB >> 15231485

Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease.

Daqing Gao1, Chiming Wei, Lei Chen, Jiawen Huang, Shiqi Yang, Anna Mae Diehl.   

Abstract

Mitochondrial generation of reactive oxygen species (ROS) is increased in mice with fatty livers induced by genetic obesity, chronic consumption of ethanol, or methionine/choline-deficient diets. Both nuclear and mitochondrial (mt) DNA are targets for ROS-induced damage and accumulate hydroxylated bases, such as 8-hydroxy-2'-deoxyguanosine (8-oxoG) and base substitution of adenine with 8-oxoG (A*8-oxoG), that introduce mutations that promote cancer as well as cell death. The mammalian homolog of the bacterial DNA mismatch repair enzyme MutY (MYH) removes A*8-oxoG from nuclear and mtDNA, reduces 8-oxoG accumulation, and restores genomic stability after ROS exposure. Cumulative damage to mtDNA occurs as fatty liver disease progresses. Therefore, differences in hepatic MYH activity may influence the severity of fatty liver disease. To evaluate this hypothesis, we compared mtH2O2 production, MYH expression, oxidative DNA damage, and hepatocyte death in healthy mice and different mouse models of fatty liver disease. The results show that diverse causes of steatohepatitis increase mtROS production, limit repair of mtDNA, and oxidatively damage DNA. However, there are important differences in the DNA repair response to oxidant stress among mouse models of fatty liver disease. Independent of the degree of mtROS generation, models with the least MYH exhibit the greatest accumulation of 8-oxoG and the most hepatocyte death. These findings raise the intriguing possibility that inherited or acquired differences in DNA repair enzyme activity may underlie some of the interindividual differences in fatty liver disease outcomes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15231485     DOI: 10.1152/ajpgi.00228.2004

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  38 in total

1.  Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies.

Authors:  Allyson K Martínez; Luca Maroni; Marco Marzioni; Syed T Ahmed; Mena Milad; Debolina Ray; Gianfranco Alpini; Shannon S Glaser
Journal:  Curr Pathobiol Rep       Date:  2014-12-01

Review 2.  Regulation of DNA glycosylases and their role in limiting disease.

Authors:  Harini Sampath; Amanda K McCullough; R Stephen Lloyd
Journal:  Free Radic Res       Date:  2012-02-06

3.  Noninvasive Diagnosis of NASH and Liver Fibrosis Within the Spectrum of NAFLD.

Authors:  Naim Alkhouri; Arthur J McCullough
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-10

Review 4.  Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.

Authors:  Mohamed A Abdelmegeed; Seung-Kwon Ha; Youngshim Choi; Mohammed Akbar; Byoung-Joon Song
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

5.  Immunohistochemistry is not an accurate first step towards the molecular diagnosis of MUTYH-associated polyposis.

Authors:  Rachel S van der Post; Carolien M Kets; Marjolijn J L Ligtenberg; Joannes H J M van Krieken; Nicoline Hoogerbrugge
Journal:  Virchows Arch       Date:  2008-11-25       Impact factor: 4.064

6.  The effect of tert-butyl hydroperoxide-induced oxidative stress on lean and steatotic rat hepatocytes in vitro.

Authors:  Otto Kučera; René Endlicher; Tomáš Roušar; Halka Lotková; Tomáš Garnol; Zdeněk Drahota; Zuzana Cervinková
Journal:  Oxid Med Cell Longev       Date:  2014-03-31       Impact factor: 6.543

Review 7.  Mitochondria and redox signaling in steatohepatitis.

Authors:  E Matthew Morris; R Scott Rector; John P Thyfault; Jamal A Ibdah
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

8.  Transcriptional profile of genes involved in oxidative stress and antioxidant defense in a dietary murine model of steatohepatitis.

Authors:  Agnieszka Gornicka; Gareth Morris-Stiff; Samjhana Thapaliya; Bettina G Papouchado; Michael Berk; Ariel E Feldstein
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

Review 9.  Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β.

Authors:  Simon Ducheix; Maria Carmela Vegliante; Gaetano Villani; Nicola Napoli; Carlo Sabbà; Antonio Moschetta
Journal:  Cell Mol Life Sci       Date:  2016-08-13       Impact factor: 9.261

Review 10.  Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?

Authors:  Naim Alkhouri; Ariel E Feldstein
Journal:  Metabolism       Date:  2016-02-02       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.